Skip to main content

Table 1 Epidemiological and clinical characteristics of cirrhotic patients admitted into Spanish intensive care units between 2005 and 2010

From: Impact of chronic hepatitis C on mortality in cirrhotic patients admitted to intensive-care unit

  Control-group CHC-group p-value
No. 4127 1138  
Males 2737 (66.3 %) 719 (63.2 %) 0.053
Age (years) 57.2 (56.7; 57.6) 58.2 (57.4; 58.9) 0.030
Length of hospital stay (days) 12.5 (11.9; 13.1) 10.7 (9.9; 11.6) <0.001
Abuse of alcohol and drugs 1622 (39.3 %) 342 (30.1 %) <0.001
Charlson comorbidity index 0.91 (0.86; 0.95) 0.75 (0.68; 0.82) <0.001
Decompensated cirrhosis 2539 (61.5 %) 777 (68.3 %) <0.001
General comorbidities
 Cardiovascular 3041 (73.7 %) 830 (72.9 %) 0.638
 Infectious without hepatitis 1352 (32.8 %) 383 (33.7 %) 0.594
 Respiratory 2212 (53.6 %) 597 (52.5 %) 0.517
 Gastrointestinal/hepatic 4029 (97.6 %) 1105 (97.1 %) 0.368
 Neurological 911 (22.1 %) 263 (23.1 %) 0.482
 Cancer 296 (7.2 %) 93 (8.2 %) 0.281
 Diabetes 692 (16.8 %) 210 (18.5 %) 0.196
  1. Values are expressed as absolute numbers (percentages) and as the mean (95 % confidence intervals). P-values were calculated by the chi-squared test or Student’s t-test, as appropriate
  2. Abbreviation: CHC chronic hepatitis C virus
\